ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 214 filers reported holding ALKERMES PLC in Q2 2014. The put-call ratio across all filers is 1.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $592,000 | -49.1% | 11,642 | -41.5% | 0.17% | -10.1% |
| Q1 2017 | $1,164,000 | -68.0% | 19,901 | -69.6% | 0.19% | -51.4% |
| Q4 2016 | $3,639,000 | +521.0% | 65,472 | +425.2% | 0.39% | +411.8% |
| Q3 2016 | $586,000 | -73.7% | 12,467 | -67.2% | 0.08% | -87.6% |
| Q3 2015 | $2,232,000 | -55.9% | 38,048 | -51.6% | 0.61% | -52.5% |
| Q2 2015 | $5,062,000 | +364.0% | 78,683 | +339.8% | 1.29% | +228.6% |
| Q1 2015 | $1,091,000 | +106.6% | 17,890 | +49.5% | 0.39% | +129.2% |
| Q1 2014 | $528,000 | +66.6% | 11,965 | +53.4% | 0.17% | +185.0% |
| Q4 2013 | $317,000 | -8.4% | 7,800 | -24.3% | 0.06% | -22.1% |
| Q3 2013 | $346,000 | – | 10,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |